Literature DB >> 11356386

Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry).

J Al Suwaidi1, W Yeh, H A Cohen, K M Detre, D O Williams, D R Holmes.   

Abstract

Balloon angioplasty of bifurcation lesions has been associated with lower success and higher complication rates than most other lesion types. The development of alternative strategies such as debulking and stenting, either alone or in combination, are currently used relatively often. The relative role of these newer approaches in improving acute or long-term outcome, however, remains uncertain. Of the total of 2,436 patients treated between July 1997 to February 1998 in the National Heart, Lung, and Blood Institute Dynamic Registry, there were 321 patients (group 1) with bifurcation lesions and 2,115 patients without any bifurcation lesions attempted (group 2). Treatment strategies in terms of major devices used were significantly different between the 2 groups (group 1 vs 2): balloon angioplasty alone (23.1% vs 26.5%), balloon angioplasty and rotational atherectomy (6.9% vs 4.4%), balloon angioplasty and stent (55.8% vs 59.9%), and balloon angioplasty, rotational atherectomy, and stent (10.3% vs 7%) with p <0.01. There were no significant differences between the groups in terms of age, gender, and frequency of prior myocardial infarction (MI) or coronary artery bypass graft surgery (CABG). Complete angiographic success was achieved in only 86% of bifurcation lesions versus 93.5% of nonbifurcation lesions (p <0.001). In-hospital complication rates were increased in patients with bifurcation lesions compared with the nonbifurcation group: MI, 3.7% versus 2.6%; CABG, 2.2% versus 1.1%; side branch occlusion, 7.3% versus 2.3% (p <0.001); and the composite of death, MI, and any CABG, 7.2% versus 5.0%. At 1-year follow-up, major adverse cardiac events were 25% higher in group 1 than in group 2 (32.1% vs 25.7%, p <0.05). We conclude that despite the widespread use of newer percutaneous devices, treatment of bifurcation lesions remains difficult and is associated with decreased success and increased complication rates compared with nonbifurcation lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11356386     DOI: 10.1016/s0002-9149(01)01482-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Comparison between measured and calculated length of side branch ostium in coronary bifurcation lesions with intravascular ultrasound.

Authors:  Hyeon Min Ryu; Byeong-Keuk Kim; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

2.  Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions.

Authors:  Yoram Richter; Adam Groothuis; Philip Seifert; Elazer R Edelman
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

3.  Quantitative coronary analysis in the Nordic Bifurcation studies.

Authors:  Niels R Holm; Helle Højdahl; Jens F Lassen; Leif Thuesen; Michael Maeng
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-07       Impact factor: 2.357

4.  Use of drug-eluting stent with provisional T-stenting technique in the treatment of renal artery bifurcation stenosis; long-term angiographic follow-up.

Authors:  Jihun Ahn; Sang-Ho Park; Won-Yong Shin; Se-Whan Lee; Seung-Jin Lee; Dong-Kyu Jin; Dohoi Kim; Tae-Hoon Kim
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

5.  Contemporary Use of Drug-eluting Stents.

Authors:  William W Chu; Ron Waksman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

6.  Utility of drug-eluting stents in complex lesions and high-risk patients.

Authors:  Eugenia Nikolsky; Gregg W Stone
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-02

7.  Intermediate term outcomes with bifurcation coronary stenting using the paclitaxel drug-eluting stent: a single centre experience.

Authors:  Nicolas W Shammas; Eric J Dippel; Gail A Shammas; Leslie Farland; Stephanie Brosius; Michael Jerin; Amber Avila; Lauren Gehbauer; Matthew Winter; Penny Stoakes; Jeannette Byrd; Peter Sharis; Jon Robken
Journal:  Int J Angiol       Date:  2008

Review 8.  Recent perspective on coronary artery bifurcation interventions.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2014-02-14

9.  Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry.

Authors:  Giuseppe Biondi-Zoccai; Imad Sheiban; Enrico Romagnoli; Stefano De Servi; Corrado Tamburino; Antonio Colombo; Francesco Burzotta; Patrizia Presbitero; Leonardo Bolognese; Leonardo Paloscia; Paolo Rubino; Gennaro Sardella; Carlo Briguori; Luigi Niccoli; Gianfranco Franco; Domenico Di Girolamo; Luigi Piatti; Cesare Greco; Davide Capodanno; Giuseppe Sangiorgi
Journal:  Clin Res Cardiol       Date:  2011-06-24       Impact factor: 5.460

10.  Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions.

Authors:  M J Grundeken; M Smits; R E Harskamp; P Damman; P Woudstra; A J Hoorweg; J Baan; E K Arkenbout; J J Piek; M M Vis; J P S Henriques; K T Koch; J G Tijssen; R J de Winter; J J Wykrzykowska
Journal:  Neth Heart J       Date:  2012-11       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.